SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-022970
Filing Date
2023-03-27
Accepted
2023-03-27 09:05:09
Documents
14
Period of Report
2023-03-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea175769-8k_silopharma.htm   iXBRL 8-K 25992
2 PRESS RELEASE DATED MARCH 27, 2023 ea175769ex99-1_silopharma.htm EX-99.1 9067
6 GRAPHIC ex99-1_001.jpg GRAPHIC 11235
  Complete submission text file 0001213900-23-022970.txt   226910

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE silo-20230327.xsd EX-101.SCH 3233
4 XBRL LABEL FILE silo-20230327_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE silo-20230327_pre.xml EX-101.PRE 22363
8 EXTRACTED XBRL INSTANCE DOCUMENT ea175769-8k_silopharma_htm.xml XML 3603
Mailing Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632
Business Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

IRS No.: 462137136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41512 | Film No.: 23761594
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl